HIF1A and neoplasm: Recently, we demonstrated that one of the mechanisms by which Spry2 exerts its “tumor suppressor” functions is by decreasing the stability of HIF1α and HIF2α with a corresponding decrease in their ability to alter transcription of the HIF1α and HIF2α target genes [85].